EFTA01156109.pdf

Fromn:"RictiKalle•cMa To: "Jeffrey Epstein" <jeevacation@gmail.com> Subject: FW: Seed I)ate: Wed, 12 Jan 2011 17:37:06 +0000 Inline-Images: image001.gif I spoke with Jamie this morning regarding their idea of you investing thru Innovium. I asked what the advantages would be and Jamie said the following: a) Smaller investment of 250,000 b) Innovium is the vehicle to help bring this company public. I respectfully told Jamie that I thought it would be years before this company went public especially with all its old payroll taxes due. In addition I asked what terms would be since in original discussed scenario 1,000,000 was going to be worth 51% or more of equity and all old debt would be forgiven. He did not have an answer and I told him that terms must be same for us to even consider smaller dollars. Jamie made a blanket statement that it has been bad timing for Seed as last year was the worst year for media companies in the last 10 years. That does not seem like an accurate statement to me. May be newspaper and print but not digital media.. We then spoke openly regarding past mistakes that have been made by Adam and that in any future role he should solely be a visionary / salesman. Jamie stated that Adam is brilliant but should not be running anything. Please advise. Rich Kahn HBRK Associates Inc. 301 East 66th Street, Suite 10F New York, NY 10065 tel 646-862-4811 fax 646-350-0954 cell 917-414-7584 From: Rich Kahn Sent: Wednesday, January 12, 2011 9:21 AM To: 'Jamie Madntosh' Subject: RE: Seed Anytime today works for me Rich Kahn HBRK Associates Inc. 301 East 66th Street, Suite 10F New York, NY 10065 tel 646-862-4811 EFTA01156109  fax 646-350-0954 cell 917-414-7584 From: Jamie Macintosh Sent: Tuesday, January 11, 2011 1:51 PM To: Rich Kahn Subject: Seed Rich, I am hoping that you will reply with a time that we could talk ? Regards, Jamie James Macintosh President and COO Innovium Media Properties Corp. 401 Bay St., Suite 2702 Toronto, Ontario MS1-1 2Y4 416-862-7003 416-862-7007 coo@innovium.ca www.innovium.ca EFTA01156110